Pracinostat in Combination With Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Condition:   Relapsed Adult AML Interventions:   Drug: Gemtuzumab Ozogamicin;   Drug: Pracinostat Sponsor:   Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials